Physician profile
Jacquelyn Plick
NPI 1609026665
$1,076.24
in general payments reported to CMS, 2019-2025
14 companies · $972 in 2025
The $972 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $104 · 2025: $972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $284.91 | 2025 | Minimed 780g |
| Tandem Diabetes Care, INC. | $206.22 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $167.88 | 2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $103.83 | 2024 | |
| Novo Nordisk INC | $63.93 | 2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $47.01 | 2025 | Korlym |
| Madrigal Pharmaceuticals | $45.43 | 2025 | Rezdiffra |
| Bayer Healthcare Pharmaceuticals INC. | $42.52 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.29 | 2025 | Jardiance |
| Amgen INC. | $21.68 | 2025 | Tepezza |
| Cequr Corporation | $18.49 | 2025 | Cequr Simplicity |
| Averitas Pharma INC. | $17.19 | 2025 | Qutenza |
| Radius Health, INC. | $16.97 | 2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $16.89 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Plick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.